Status:
COMPLETED
The Effects of Administration of Combined Docosahexaenoic Acid and Vitamin E Supplements on Spermatogram and Seminal Plasma Oxidative Stress in Infertile Men With Asthenozoospermia
Lead Sponsor:
National Nutrition and Food Technology Institute
Conditions:
Asthenozoospermia
Eligibility:
MALE
20-45 years
Phase:
PHASE2
PHASE3
Brief Summary
Since docosahexaenoic acid (DHA) level in sperm membrane has been shown to be decreased in asthenozoospermic men, the investigators hypothesized that DHA supplementation may improve it. Furthermore, t...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Willing to participate in the study and filling out the informed consent form
- should be infertile (no conception after 12 months intercourse without any contraception)
- age 20-45 y.o, idiopathic asthenospermia according to WHO criteria
- normal hormonal profile
- Exclusion criteria:
- any infection in genitourinary (GU) tract
- any anatomical abnormality in GU tract
- any chronic disease during last 3 months
- any surgery in GU tract
- consumption of omega-3 fatty acids and/or vitamin E supplements during last 3 months
Exclusion
Key Trial Info
Start Date :
December 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01846325
Start Date
December 1 2013
End Date
May 1 2015
Last Update
June 16 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.